学術論文　2012

  1. Yamashita A, Salam KA, Furuta A, Matsuda Y, Fujita O, Tani H, Fujita Y, et al. Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia. Mar Drugs 2012;10:744-761.
  2. Tsukui Y, Mochizuki H, Hoshino Y, Kawakami S, Kuno T, Fukasawa Y, Iwamoto F, et al. Factors contributing to the overall survival in patients with hepatocellular carcinoma treated by sorafenib. Hepatogastroenterology 2012;59:2536-2539.
  3. Takano S, Fukasawa M, Sato T, Takahashi E, Kadokura M, Shindo H, Enomoto N. Migration of pancreatic spontaneous dislodgement stent to the appendix. Dig Endosc 2012;24:481.
  4. Sueki R, Maekawa S, Miura M, Kadokura M, Komase K, Shindo H, Kanayama A, et al. Correlation between pretreatment viral sequences and the emergence of lamivudine resistance in hepatitis B virus infection. J Med Virol 2012;84:1360-1368.
  5. Shindo H, Maekawa S, Komase K, Sueki R, Miura M, Kadokura M, Shindo K, et al. Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients. Hepatol Int 2012;6:482-490.
  6. Sakamoto M, Enomoto N. [Anti HCV drugs–ribavirin, telaprevir]. Nihon Rinsho 2012;70:614-619.
  7. Saito H, Ito K, Sugiyama M, Matsui T, Aoki Y, Imamura M, Murata K, et al. Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients. Hepatol Res 2012;42:958-965.
  8. Osada M, Kaneko M, Sakamoto M, Endoh M, Takigawa K, Suzuki-Inoue K, Inoue O, et al. Causes of thrombocytopenia in chronic hepatitis C viral infection. Clin Appl Thromb Hemost 2012;18:272-280.
  9. Ohtaka M, Tatsumi A, Fukasawa M, Yamaguchi T, Uetake T, Ohtsuka H, Sato T, et al. Complete remission of gastric plasmacytoma following eradication of “Candidatus Helicobacter heilmannii”. Clin J Gastroenterol 2012;5:158-163.
  10. Miura M, Maekawa S, Kadokura M, Sueki R, Komase K, Shindo H, Ohmori T, et al. Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis C. Hepatol Int 2012;6:386-396.
  11. Maekawa S, Sakamoto M, Miura M, Kadokura M, Sueki R, Komase K, Shindo H, et al. Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection. Hepatology 2012;56:1611-1621.
  12. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Enomoto N, Matsuda M, et al. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci 2012;11:291-297.
  13. Fujimoto Y, Salam KA, Furuta A, Matsuda Y, Fujita O, Tani H, Ikeda M, et al. Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp. PLoS One 2012;7:e48685.
  14. Asahina Y, Tsuchiya K, Muraoka M, Tanaka K, Suzuki Y, Tamaki N, Hoshioka Y, et al. Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response. Hepatology 2012;55:20-29.